Abstract:Biomedical industry is a strategic emerging industry in China, especially the outbreak of the Covid pandemic. The biomedical industry is characterized by high risk, high investment, high technology and long cycle, and each stage contains risks and challenges. How to optimize the policy environment and financial environment, explore the unique “policy” and “finance” model for the development of the biomedical industry, and improve the innovation performance has become an important issue. This paper analyzes the relationship among industry policy, financial institution and innovation performance in the biomedical industry from the configuration perspective, combining necessary condition analysis (NCA) and qualitative comparative analysis (QCA) research methods, using the A-share listed enterprises in Shanghai and Shenzhen in the biomedical industry from 2012 to 2020 as the research objects. It is found that (1) individual policy preference or financial institution dimension cannot constitute a necessary condition for generating high innovation performance of biomedical company, but increasing tax incentive and raising the proportion of equity-based financing method play a significant role in generating high innovation performance; (2) four “political” and “financial “synergistic grouping paths can generate high innovation performance, including tax incentives, financial institutions’ professional level and institutional background synergistic drive type; government subsidy, financing method and financial institutions’ professional level synergistic drive type; tax incentive and financing method synergistic drive type; tax incentive and institutional background drive type. Different synergistic grouping paths represent various ways to achieve high innovation performance of biomedical enterprise. In addition, the results show that the two “political” and “financial” groupings lead to low-to-medium innovation performance, which indicates that industry policy plays a very important role in the innovation performance and that the government’s support for emerging industries through policy is a significant force for the innovation development. This paper introduces the “political” and “financial” aspects to investigate the configuration effect of industry policy and financial institutions on the innovation performance of biomedical enterprise. The findings have important theoretical and practical implications for revealing the synergistic path of high innovation performance in the Chinese biomedical industry.

The Evaluation System of Venture Investment on Chinese Bio Medicine Industry

Analysis of the Survival of High-tech Ventures

Analysis of Investment Value of Traditional Chinese Medicine Enterprises Based on Genetic Algorithm

Venture Capital and Patent Activities in China: Multi-Case Study in Bio-Pharmaceutical Industry

An Empirical Study on Investment Stage Selection of Chinese Venture Capital Institutions and Its Performance Effects

Factor Analysis for Financial Performance Evaluation of Listed Chinese Medicine Companies

Representative Stock Analysis in Chinese Medical Industry and Relevant Investment Recommendations

What Affects the Venture Capital for Start-Ups: from the Perspective of Patent Signal of Chinese Bio-Pharmaceutical

Financial Analysis and Valuation Study of Chinese Listed Companies: The Case of “Tongce” Medical

Validity Analysis on the Impact of the Supporting Environment to the Venture Capital Development

[Construction of model for multidimensional evaluation of value and risk of Chinese patent medicine]

Chinese Medical Device Market and The Investment Vector

Financial Risk Analysis of the Pharmaceutical Industry Based on Z-score Model: A Case Study of Changjiang Health

Analysis of Investment Value in the Traditional Chinese Medicine Industry: A Case Study of Yiling Pharmaceutical Co., Ltd.

Development Environment and SWOT Analysis of Biomedical SMEs after COVID-19: Evidence from China

Research on Risk Avoidance Methods of Venture Capital

Analysis of the Investment Features of Stocks of Valuation System with Chinese Characteristics Based on Hierarchical Cluster Method

Analyzing and Thinking on the Limitative Factors of Venture Investment in China

The influence of “industry policy” and “financial institution” configuration effect on innovation performance of China’s biomedical industry-based on necessary condition analysis and qualitative comparative analysis

STUDY OF THE PROBLEMS EXISTING IN THE PROCESS OF EQUITY FINANCING OF SMALL AND MEDIUM-SIZED INNOVATIVE ENTERPRISES ON THE BASIS OF A QUESTIONNAIRE SURVEY OF INVESTMENT INSTITUTIONS

RESEARCH ON CHINESE VENTURE CAPITAL INDUSTRY'S EXISTENT QUESTIONS AND THEIR COUNTERMEASURES